Your browser doesn't support javascript.
loading
How do we engage people in testing for COVID-19? A rapid qualitative evaluation of a testing programme in schools, GP surgeries and a university.
Watson, Daniella; Baralle, Natalia Laverty; Alagil, Jawahr; Anil, Krithika; Ciccognani, Sandy; Dewar-Haggart, Rachel; Fearn, Sarah; Groot, Julia; Knowles, Kathryn; Meagher, Claire; McGrath, Carmel; Muir, Sarah; Musgrove, Jo; Glyn-Owen, Kate; Woods-Townsend, Kath; Mortimore, Andrew; Roderick, Paul; Baird, Janis; Inskip, Hazel; Godfrey, Keith; Barker, Mary.
Afiliação
  • Watson D; School of Human Development and Health, Faculty of Medicine, Global Health Research Institute, University of Southampton, Southampton, United Kingdom. D.Watson@soton.ac.uk.
  • Baralle NL; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Alagil J; School of Health Sciences, Faculty of Life and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
  • Anil K; College of Applied Medical Sciences, Health Rehabilitation Department, King Saud University, Riyadh, Kingdom of Saudi Arabia.
  • Ciccognani S; School of Health Professions, Faculty of Health and Human Sciences, University of Plymouth, Plymouth, United Kingdom.
  • Dewar-Haggart R; School of Health Sciences, Faculty of Life and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
  • Fearn S; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Groot J; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Knowles K; Department of Psychology, University of Bath, Bath, United Kingdom.
  • Meagher C; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • McGrath C; School of Health Sciences, Faculty of Life and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
  • Muir S; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Musgrove J; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Glyn-Owen K; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Woods-Townsend K; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Mortimore A; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Roderick P; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Baird J; Southampton Education School, Faculty of Social Sciences, University of Southampton, Southampton, United Kingdom.
  • Inskip H; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Godfrey K; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Barker M; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
BMC Public Health ; 22(1): 305, 2022 02 14.
Article em En | MEDLINE | ID: mdl-35164728
ABSTRACT

BACKGROUND:

The UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high levels of engagement with communities and individuals to ensure the effectiveness of any COVID-19 testing programme. A novel pilot health surveillance programme to assess the feasibility of weekly community RT-LAMP (Reverse transcription loop-mediated isothermal amplification) testing for the SARS-CoV-2 virus using saliva samples collected at home was developed and piloted by the University of Southampton and Southampton City Council.

METHODS:

Rapid qualitative evaluation was conducted to explore experiences of those who took part in the programme, of those who declined and of those in the educational and healthcare organisations involved in the pilot testing who were responsible for roll-out. This included 77 interviews and 20 focus groups with 223 staff, students, pupils and household members from four schools, one university, and one community healthcare NHS trust. The insights generated and informed the design and modification of the Southampton COVID-19 Saliva Testing Programme and the next phase of community-testing.

RESULTS:

Discussions revealed that high levels of communication, trust and convenience were necessary to ensure people's engagement with the programme. Participants felt reassured by and pride in taking part in this novel programme. They suggested modifications to reduce the programme's environmental impact and overcome cultural barriers to participation.

CONCLUSIONS:

Participants' and stakeholders' motivations, challenges and concerns need to be understood and these insights used to modify the programme in a continuous, real-time process to ensure and sustain engagement with testing over the extended period necessary. Community leaders and stakeholder organisations should be involved throughout programme development and implementation to optimise engagement.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste para COVID-19 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste para COVID-19 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article